Income Statement China Isotope & Radiation Corporation

Stocks

1763

CNE1000031F4

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. Other stock markets 04:08:11 2026-06-26 EDT			5-day change	1st Jan Change
17.30 ^HKD	-2.37%		-11.01%	-14.36%

06-18	China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2025, Payable on Before 17 August 2026	CI
06-18	China Isotope & Radiation Corporation Appoints Zhang Guoliang as A Member of Legal Affairs Committee of the Board and A Member of Science and Technology Innovation Committee of the Board	CI

04bd86b26988ed179307c5184.OMMT2o4LB4QMWxc_vlwlLXTrVvYmjWM5UyIBycZwch8.AKFcsPhxKso_LWZ53QtAFBiiHp9v2wdcAhRloLZCGlFyi3C2yk5M_l4ycA

Published financial data: CHINA ISOTOPE & RADIATION CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	5.14B	6.15B	6.63B	7.57B	7.19B
Total Revenues	5.14B	6.15B	6.63B	7.57B	7.19B
Cost of Goods Sold, Total	1.9B	2.63B	3.15B	3.89B	3.57B
Gross Profit	3.24B	3.51B	3.48B	3.68B	3.62B
Selling General & Admin Expenses, Total	2.32B	2.36B	2.41B	2.33B	2.33B
Provision for Bad Debts	11M	31.19M	71.24M	45.54M	44.47M
R&D Expenses	196M	301M	306M	300M	302M
Other Operating Expenses	-28.36M	-53.77M	-50.32M	-72.24M	-74.25M
Other Operating Expenses, Total	2.5B	2.64B	2.73B	2.6B	2.6B
Operating Income	743M	874M	750M	1.08B	1.02B
Interest Expense, Total	-34.04M	-32.72M	-34.83M	-47.2M	-64.05M
Interest And Investment Income	30.99M	51.69M	36.57M	34.09M	37.38M
Net Interest Expenses	-3.05M	18.97M	1.74M	-13.12M	-26.67M
Income (Loss) On Equity Invest.	60.66M	42.17M	16.98M	7.26M	16.55M
Currency Exchange Gains (Loss)	-1.65M	-13.29M	-4.39M	-9.44M	-7.82M
Other Non Operating Income (Expenses)	-	-	-	-	-5.83M
EBT, Excl. Unusual Items	799M	922M	764M	1.06B	996M
Gain (Loss) On Sale Of Investments	4.55M	-	-	-19.34M	-796K
Gain (Loss) On Sale Of Assets	-683K	-1.12M	158M	-197K	9.56M
Asset Writedown	-	-	-	-	-224K
Other Unusual Items	-	125K	-	160K	80K
EBT, Incl. Unusual Items	803M	921M	922M	1.05B	1B
Income Tax Expense	130M	166M	146M	166M	340M
Earnings From Continuing Operations	673M	755M	776M	880M	665M
Net Income to Company	673M	755M	776M	880M	665M
Minority Interest	-337M	-363M	-405M	-473M	-337M
Net Income - (IS)	336M	392M	371M	407M	327M
Net Income to Common Incl Extra Items	336M	392M	371M	407M	327M
Net Income to Common Excl. Extra Items	336M	392M	371M	407M	327M
Per Share Items
Net EPS - Basic	1.05	1.22	1.16	1.27	1.02
Basic EPS - Continuing Operations	1.05	1.22	1.16	1.27	1.02
Basic Weighted Average Shares Outstanding	320M	320M	320M	320M	320M
Net EPS - Diluted	1.05	1.22	1.16	1.27	1.02
Diluted EPS - Continuing Operations	1.05	1.22	1.16	1.27	1.02
Diluted Weighted Average Shares Outstanding	320M	320M	320M	320M	320M
Normalized Basic EPS	0.51	0.67	0.23	0.6	0.89
Normalized Diluted EPS	0.51	0.67	0.23	0.6	0.89
Dividend Per Share	0.38	0.44	0.31	0.38	0.31
Payout Ratio	17.18	30.87	38	30.32	38.07
Supplemental Items
EBITDA	901M	1.05B	973M	1.29B	1.24B
EBITA	754M	882M	762M	1.09B	1.03B
EBIT	743M	874M	750M	1.08B	1.02B
EBITDAR	904M	1.06B	-	-	-
Effective Tax Rate - (Ratio)	16.15	18.03	15.86	15.85	33.82
Current Domestic Taxes	144M	174M	-	232M	400M
Total Current Taxes	144M	174M	167M	232M	400M
Deferred Domestic Taxes	-14.08M	-7.88M	-	-66.68M	-60.01M
Total Deferred Taxes	-14.08M	-7.88M	-20.52M	-66.68M	-60.01M
Normalized Net Income	162M	213M	72.35M	192M	285M
Interest Capitalized	5.13M	5.33M	9.61M	16.43M	16.43M
Interest on Long-Term Debt	26.8M	26.09M	3.23M	5.22M	15M
Non-Cash Pension Expense	1.76M	1.68M	1.32M	1.22M	1.14M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Marketing Expenses	-	-	-	-	-
Selling and Marketing Expenses	1.82B	1.79B	1.77B	1.62B	1.45B
General and Administrative Expenses	498M	573M	636M	705M	880M
Research And Development Expense From Footnotes	196M	301M	306M	300M	302M
Net Rental Expense, Total	2.91M	9.03M	-	-	-
Imputed Operating Lease Interest Expense	1.14M	3.16M	-	-	-
Imputed Operating Lease Depreciation	1.78M	5.87M	-	-	-
Maintenance & Repair Expenses, Total	-	-	-	-	-
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.75B	2.92B	2.89B	2.65B	2.59B
Short Term Investments	40.62M	25.41M	48.91M	31.83M	28.77M
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	2.79B	2.95B	2.94B	2.68B	2.62B
Accounts Receivable, Total	2.85B	3.53B	3.9B	4.98B	4.89B
Other Receivables	23.19M	59.71M	76.94M	98.92M	74.12M
Total Receivables	2.87B	3.59B	3.97B	5.08B	4.96B
Inventory	904M	914M	1.15B	993M	1.55B
Other Current Assets, Total	89.92M	61.35M	129M	164M	202M
Total Current Assets	6.66B	7.51B	8.19B	8.92B	9.34B
Gross Property Plant And Equipment	3.47B	3.94B	4.79B	5.73B	6.26B
Accumulated Depreciation	-961M	-1.11B	-1.19B	-1.4B	-1.61B
Net Property Plant And Equipment	2.51B	2.82B	3.6B	4.33B	4.64B
Long-term Investments	797M	840M	780M	733M	804M
Goodwill	44.04M	30.76M	81.53M	81.53M	77.41M
Other Intangibles, Total	156M	161M	212M	320M	446M
Deferred Tax Assets Long-Term	214M	221M	220M	285M	336M
Other Long-Term Assets, Total	92.1M	98.5M	102M	101M	73.06M
Total Assets	10.47B	11.69B	13.19B	14.77B	15.72B
Liabilities
Accounts Payable, Total	338M	488M	627M	791M	719M
Accrued Expenses, Total	1.79B	2.02B	1.95B	2.02B	2.12B
Short-term Borrowings	112M	8.01M	191M	505M	856M
Current Portion of Long-Term Debt	506M	10.19M	5.42M	435M	40.05M
Current Portion of Leases	53.37M	28.52M	20.88M	26.02M	27.52M
Current Income Taxes Payable	69.4M	95.73M	67.53M	75.58M	79.92M
Unearned Revenue Current, Total	341M	484M	443M	310M	527M
Other Current Liabilities	757M	857M	945M	864M	916M
Total Current Liabilities	3.97B	3.99B	4.25B	5.02B	5.29B
Long-Term Debt	145M	787M	1.45B	1.55B	1.75B
Long-Term Leases	40.5M	51.63M	37.32M	56.75M	68.14M
Unearned Revenue Non Current	43.88M	96.26M	122M	177M	244M
Pension & Other Post Retirement Benefits	49.9M	53.94M	44.01M	55.12M	53.88M
Deferred Tax Liability Non Current	17.35M	18.24M	8.88M	7.62M	6.2M
Other Non Current Liabilities	175M	138M	140M	154M	173M
Total Liabilities	4.44B	5.13B	6.05B	7.02B	7.58B
Common Stock, Total	320M	320M	320M	320M	320M
Retained Earnings	1.7B	1.97B	2.2B	2.48B	2.68B
Comprehensive Income and Other	2.16B	2.17B	2.17B	2.21B	2.22B
Total Common Equity	4.18B	4.47B	4.69B	5.01B	5.23B
Minority Interest	1.85B	2.09B	2.45B	2.74B	2.91B
Total Equity	6.03B	6.55B	7.14B	7.74B	8.13B
Total Liabilities And Equity	10.47B	11.69B	13.19B	14.77B	15.72B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	320M	320M	320M	320M	320M
ECS Total Common Shares Outstanding	320M	320M	320M	320M	320M
Book Value / Share	13.07	13.96	14.67	15.65	16.34
Tangible Book Value	3.98B	4.27B	4.4B	4.6B	4.7B
Tangible Book Value Per Share	12.44	13.36	13.75	14.39	14.7
Total Debt	857M	885M	1.7B	2.57B	2.74B
Net Debt	-1.93B	-2.06B	-1.24B	-109M	119M
Debt Equivalent of Unfunded Proj. Benefit Obligation	49.9M	57.03M	46.74M	57.85M	56.64M
Debt Equivalent Oper. Leases	23.3M	72.26M	-	-	-
Minority Interest, Total (Incl. Fin. Div)	1.85B	2.09B	2.45B	2.74B	2.91B
Equity Method Investments, Total	647M	678M	623M	571M	625M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	199M	158M	239M	264M	462M
Inventories - Work In Process, Total	87.23M	112M	96.66M	152M	241M
Inventories - Finished Goods, Total	395M	400M	466M	383M	696M
Inventories - Others	12.36M	8.62M	14.02M	20.16M	25.22M
Buildings, Total	967M	1.17B	1.29B	1.79B	2.21B
Machinery, Total	1.23B	1.39B	1.78B	1.84B	2.16B
Full Time Employees	3.12K	3.37K	3.1K	3.37K	3.58K
Accumulated Allowance for Doubtful Accounts (Supple)	157M	185M	205M	233M	261M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	336M	392M	371M	407M	327M
Depreciation & Amortization - CF	180M	205M	243M	224M	240M
Amortization of Goodwill and Intangible Assets - (CF)	11.48M	8.27M	11.87M	11.12M	14.69M
Depreciation & Amortization, Total	191M	213M	255M	235M	255M
Amortization of Deferred Charges, Total - (CF)	6.18M	7.55M	9.19M	9.42M	9.89M
(Gain) Loss From Sale Of Asset	683K	1.12M	-158M	197K	-9.56M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	19.34M	7.34M
Asset Writedown & Restructuring Costs	-	17.33M	-	3K	224K
(Income) Loss On Equity Investments - (CF)	-65.4M	-48.57M	-22.57M	-11.74M	-36.64M
Provision and Write-off of Bad Debts	-	-	68.42M	31.9M	34.3M
Other Operating Activities, Total	360M	328M	336M	428M	332M
Change In Accounts Receivable	-463M	-678M	-527M	-1.12B	1.81M
Change In Inventories	-102M	14.29M	-157M	1.93M	-606M
Change In Accounts Payable	138M	150M	161M	167M	-59.92M
Change in Unearned Revenues	-	-	-	-	-
Change in Other Net Operating Assets	393M	466M	-250M	-27.63M	283M
Cash from Operations	794M	863M	84.96M	142M	538M
Capital Expenditure	-428M	-534M	-898M	-1.03B	-567M
Sale of Property, Plant, and Equipment	810K	39.76M	48K	224K	28K
Cash Acquisitions	-85.98M	-23.03M	-75.86M	-11.56M	-
Divestitures	-	-	225M	-	-899K
Investment in Marketable and Equity Securities, Total	-429M	-146M	202M	332M	52.14M
Other Investing Activities, Total	34.51M	157M	116M	147M	167M
Cash from Investing	-907M	-507M	-430M	-565M	-349M
Long-Term Debt Issued, Total	195M	735M	910M	1.52B	1.49B
Total Debt Issued	195M	735M	910M	1.52B	1.49B
Long-Term Debt Repaid, Total	-132M	-748M	-115M	-678M	-1.32B
Total Debt Repaid	-132M	-748M	-115M	-678M	-1.32B
Issuance of Common Stock	-	-	-	-	-
Common Dividends Paid	-57.67M	-121M	-141M	-123M	-125M
Common & Preferred Stock Dividends Paid	-57.67M	-121M	-141M	-123M	-125M
Other Financing Activities, Total	-103M	-157M	-169M	-217M	-213M
Cash from Financing	-97.44M	-291M	484M	500M	-169M
Foreign Exchange Rate Adjustments	328K	-	189K	-2.68M	-1.19M
Net Change in Cash	-210M	64.54M	140M	74.69M	19.43M
Supplemental Items
Cash Interest Paid	34.24M	31.23M	3.23M	2.65M	2.86M
Cash Income Tax Paid (Refund)	126M	148M	195M	225M	395M
Levered Free Cash Flow	170M	157M	-805M	-1.11B	127M
Unlevered Free Cash Flow	191M	177M	-783M	-1.08B	167M
Change In Net Working Capital	42.7M	55.28M	618M	963M	168M
Net Debt Issued / Repaid	63.35M	-13.19M	794M	840M	169M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.72	4.93	3.75	4.83	4.18
Return on Total Capital	7.06	7.62	5.73	7.05	6.01
Return On Equity %	11.67	11.99	11.29	11.82	8.37
Return on Common Equity	8.32	9.06	8.1	8.39	6.4
Margin Analysis
Gross Profit Margin %	63.03	57.18	52.48	48.62	50.39
SG&A Margin	45.11	38.45	36.26	30.75	32.42
EBITDA Margin %	17.52	17.15	14.66	16.97	17.22
EBITA Margin %	14.66	14.35	11.48	14.4	14.39
EBIT Margin %	14.44	14.21	11.3	14.26	14.18
Income From Continuing Operations Margin %	13.08	12.28	11.7	11.61	9.25
Net Income Margin %	6.53	6.37	5.59	5.37	4.56
Net Avail. For Common Margin %	6.53	6.37	5.59	5.37	4.56
Normalized Net Income Margin	3.15	3.47	1.09	2.54	3.97
Levered Free Cash Flow Margin	3.3	2.55	-12.13	-14.59	1.76
Unlevered Free Cash Flow Margin	3.72	2.89	-11.8	-14.2	2.32
Asset Turnover
Asset Turnover	0.52	0.55	0.53	0.54	0.47
Fixed Assets Turnover	2.18	2.3	2.03	1.91	1.6
Receivables Turnover (Average Receivables)	1.97	1.93	1.79	1.71	1.46
Inventory Turnover (Average Inventory)	2.37	2.89	3.05	3.63	2.8
Short Term Liquidity
Current Ratio	1.68	1.88	1.93	1.78	1.76
Quick Ratio	1.43	1.64	1.63	1.54	1.43
Operating Cash Flow to Current Liabilities	0.2	0.22	0.02	0.03	0.1
Days Sales Outstanding (Average Receivables)	185.17	189.42	204.06	214.46	250.62
Days Outstanding Inventory (Average Inventory)	154.33	126.13	119.69	100.88	130.16
Average Days Payable Outstanding	46.65	57.08	60.35	69.52	66.86
Cash Conversion Cycle (Average Days)	292.85	258.47	263.39	245.83	313.92
Long Term Solvency
Total Debt/Equity	14.2	13.5	23.83	33.21	33.67
Total Debt / Total Capital	12.44	11.9	19.25	24.93	25.19
LT Debt/Equity	3.07	12.79	20.79	20.73	22.32
Long-Term Debt / Total Capital	2.69	11.27	16.79	15.56	16.69
Total Liabilities / Total Assets	42.42	43.92	45.88	47.56	48.25
EBIT / Interest Expense	21.82	26.7	21.53	22.88	15.91
EBITDA / Interest Expense	27.43	33.21	28.85	27.86	19.89
(EBITDA - Capex) / Interest Expense	14.87	16.89	3.08	6	11.04
Total Debt / EBITDA	0.92	0.81	1.69	1.96	2.15
Net Debt / EBITDA	-2.07	-1.9	-1.23	-0.08	0.09
Total Debt / (EBITDA - Capex)	1.69	1.6	15.87	9.08	3.87
Net Debt / (EBITDA - Capex)	-3.82	-3.73	-11.56	-0.38	0.17
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	20.34	19.49	7.82	14.16	-5.11
Gross Profit, 1 Yr. Growth %	23.93	8.41	-1.01	5.76	-1.66
EBITDA, 1 Yr. Growth %	25.65	16.95	-8.01	32.15	-3.74
EBITA, 1 Yr. Growth %	26.89	16.92	-13.77	43.26	-5.23
EBIT, 1 Yr. Growth %	27.96	17.61	-14.31	44.05	-5.61
Earnings From Cont. Operations, 1 Yr. Growth %	41.54	12.11	2.77	13.32	-24.44
Net Income, 1 Yr. Growth %	57.2	16.64	-5.43	9.62	-19.48
Normalized Net Income, 1 Yr. Growth %	45.45	31.49	-66.06	166.06	48.1
Diluted EPS Before Extra, 1 Yr. Growth %	57.2	16.64	-5.43	9.62	-19.48
Accounts Receivable, 1 Yr. Growth %	20.35	23.79	10.61	27.84	-1.83
Inventory, 1 Yr. Growth %	28.46	1.11	25.83	-13.78	56.04
Net Property, Plant and Equip., 1 Yr. Growth %	13.7	12.25	22.5	20.19	7.31
Total Assets, 1 Yr. Growth %	14.03	11.57	11.89	11.94	6.43
Tangible Book Value, 1 Yr. Growth %	7.56	7.41	2.87	4.63	2.18
Common Equity, 1 Yr. Growth %	7.4	6.84	5.03	6.65	4.42
Cash From Operations, 1 Yr. Growth %	172.11	8.6	-90.16	67.71	277.83
Capital Expenditures, 1 Yr. Growth %	4.34	24.85	55.73	14.99	-45.09
Levered Free Cash Flow, 1 Yr. Growth %	-164.17	-7.62	-668.6	37.29	-111.47
Unlevered Free Cash Flow, 1 Yr. Growth %	-178.35	-7.2	-581.65	37.34	-115.51
Dividend Per Share, 1 Yr. Growth %	109.6	16.62	-28.95	21.81	-19.48
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	13.56	19.92	13.58	10.95	4.08
Gross Profit, 2 Yr. CAGR %	7.04	15.91	3.64	2.32	1.98
EBITDA, 2 Yr. CAGR %	8.18	21.22	3.89	10.25	12.79
EBITA, 2 Yr. CAGR %	5.74	21.8	0.48	11.15	16.52
EBIT, 2 Yr. CAGR %	5.3	22.67	0.46	11.1	16.6
Earnings From Cont. Operations, 2 Yr. CAGR %	3.78	25.97	7.39	7.92	-7.47
Net Income, 2 Yr. CAGR %	1.02	35.41	5.11	1.82	-6.05
Normalized Net Income, 2 Yr. CAGR %	-0.42	38.3	-33.17	-4.97	98.51
Diluted EPS Before Extra, 2 Yr. CAGR %	1.02	35.41	5.11	1.82	-6.05
Accounts Receivable, 2 Yr. CAGR %	14.15	22.06	16.91	18.91	12.02
Inventory, 2 Yr. CAGR %	29.17	13.97	12.87	4.16	15.99
Net Property, Plant and Equip., 2 Yr. CAGR %	12.46	12.97	19.71	21.34	13.57
Total Assets, 2 Yr. CAGR %	8.83	12.79	12.23	11.92	9.15
Tangible Book Value, 2 Yr. CAGR %	5.03	7.49	5.16	3.75	3.4
Common Equity, 2 Yr. CAGR %	5.44	7.12	5.97	5.83	5.53
Cash From Operations, 2 Yr. CAGR %	14.88	71.91	-67.3	-59.37	151.73
Capital Expenditures, 2 Yr. CAGR %	-14.9	14.14	44.87	33.82	-20.54
Levered Free Cash Flow, 2 Yr. CAGR %	8.24	-23.01	117.72	179.4	-60.32
Unlevered Free Cash Flow, 2 Yr. CAGR %	19.34	-14.73	102.45	157.2	-53.85
Dividend Per Share, 2 Yr. CAGR %	64.94	56.34	-8.98	-6.97	-0.96
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	16.54	15.5	15.79	13.77	5.31
Gross Profit, 3 Yr. CAGR %	12.11	7.5	10	4.34	0.98
EBITDA, 3 Yr. CAGR %	10.37	11.03	10.69	12.56	5.38
EBITA, 3 Yr. CAGR %	7.77	9.34	8.61	13.09	5.4
EBIT, 3 Yr. CAGR %	7.31	9.25	8.9	13.28	5.22
Earnings From Cont. Operations, 3 Yr. CAGR %	4.66	6.49	17.74	9.33	-4.17
Net Income, 3 Yr. CAGR %	1.41	5.98	20.21	6.59	-5.85
Normalized Net Income, 3 Yr. CAGR %	-1.16	9.25	-13.39	5.92	10.18
Diluted EPS Before Extra, 3 Yr. CAGR %	-3.09	5.98	20.21	6.59	-5.85
Accounts Receivable, 3 Yr. CAGR %	18.15	17.28	18.05	20.45	11.55
Inventory, 3 Yr. CAGR %	27.03	19.04	17.85	3.18	19.18
Net Property, Plant and Equip., 3 Yr. CAGR %	23.32	12.39	17.67	19.87	16.47
Total Assets, 3 Yr. CAGR %	14.91	9.73	12.82	12.13	10.06
Tangible Book Value, 3 Yr. CAGR %	4.89	5.82	5.95	4.98	3.22
Common Equity, 3 Yr. CAGR %	6.07	5.9	6.45	6.2	5.36
Cash From Operations, 3 Yr. CAGR %	11.33	12.75	-33.73	-43.6	-14.56
Capital Expenditures, 3 Yr. CAGR %	-17.11	-3.31	29.86	34.13	-0.56
Levered Free Cash Flow, 3 Yr. CAGR %	-18.77	2.67	44.89	86.7	-3.62
Unlevered Free Cash Flow, 3 Yr. CAGR %	-15.17	9.74	47.54	77.89	0.85
Dividend Per Share, 3 Yr. CAGR %	11.5	46.94	20.2	0.31	-11.34
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	16.83	18.13	15.35	13.68	10.96
Gross Profit, 5 Yr. CAGR %	13.82	13.27	8.64	5.41	6.72
EBITDA, 5 Yr. CAGR %	10.39	12.79	7.73	10.79	11.52
EBITA, 5 Yr. CAGR %	9.09	11.41	4.79	10.09	11.71
EBIT, 5 Yr. CAGR %	8.81	11.27	4.52	10.02	11.92
Earnings From Cont. Operations, 5 Yr. CAGR %	9.15	9.67	5.74	7.07	6.92
Net Income, 5 Yr. CAGR %	5.08	7.6	2.88	4.33	8.92
Normalized Net Income, 5 Yr. CAGR %	2.02	7.95	-15.48	3.34	20.68
Diluted EPS Before Extra, 5 Yr. CAGR %	-4.34	0.91	0.11	4.33	8.92
Accounts Receivable, 5 Yr. CAGR %	18.59	18.55	17.65	17.89	15.6
Inventory, 5 Yr. CAGR %	31.99	28.3	21.17	12.88	17.1
Net Property, Plant and Equip., 5 Yr. CAGR %	32.83	29.79	21.87	16.85	16.01
Total Assets, 5 Yr. CAGR %	23.93	20	13.83	10.8	11.34
Tangible Book Value, 5 Yr. CAGR %	34.35	18.47	5	5	4.92
Common Equity, 5 Yr. CAGR %	35.13	19.03	6.03	5.89	6.08
Cash From Operations, 5 Yr. CAGR %	11.66	14.95	-31.8	-25.04	13.02
Capital Expenditures, 5 Yr. CAGR %	27.7	16.81	3.63	11.81	6.69
Levered Free Cash Flow, 5 Yr. CAGR %	7.44	-2.85	20.5	50.12	-13.69
Unlevered Free Cash Flow, 5 Yr. CAGR %	8.66	-0.82	20.13	51.64	-7.32
Dividend Per Share, 5 Yr. CAGR %	-	-	2.81	22.39	11.24